Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brad Jones

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Cell Reports|April 4, 2019
HIV Controllers Exhibit Effective CD8<sup>+</sup> T Cell Recognition of HIV-1-Infected Non-activated CD4<sup>+</sup> T CellsBlandine Monel, Annmarie McKeon, Pedro Lamothe-Molina, et al.
Biomaterials|December 10, 2016
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cellsR Brad Jones, Stephanie Mueller, Sudha Kumari, et al.
Glycoconjugate Journal|June 29, 2010
A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanismsAmanda L Harrison, Martin L Olsson, R Brad Jones, et al.
Journal of Translational Medicine|September 17, 2014
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasisRashmi Gupta, Henri-Alexandre Michaud, Xue Zeng, et al.
Frontiers in Immunology|October 4, 2021
Characterizing the Relationship Between Neutralization Sensitivity and <i>env</i> Gene Diversity During ART SuppressionAndrew Wilson, Leyn Shakhtour, Adam Ward, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2018
HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope BreadthsShabnum Patel, Elizabeth Chorvinsky, Shuroug Albihani, et al.
Journal of Virology|March 29, 2019
Modeling HIV-1 Latency Using Primary CD4<sup>+</sup> T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral TherapyHiroshi Takata, Cari Kessing, Aaron Sy, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
AIDS Research and Human Retroviruses|September 11, 2018
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral TherapyNathaniel D Bachtel, Greta A Beckerle, Talia M Mota, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity Zang, Eva M Stevenson, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Cell Reports|April 4, 2019
HIV Controllers Exhibit Effective CD8<sup>+</sup> T Cell Recognition of HIV-1-Infected Non-activated CD4<sup>+</sup> T CellsBlandine Monel, Annmarie McKeon, Pedro Lamothe-Molina, et al.
Biomaterials|December 10, 2016
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cellsR Brad Jones, Stephanie Mueller, Sudha Kumari, et al.
Glycoconjugate Journal|June 29, 2010
A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanismsAmanda L Harrison, Martin L Olsson, R Brad Jones, et al.
Journal of Translational Medicine|September 17, 2014
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasisRashmi Gupta, Henri-Alexandre Michaud, Xue Zeng, et al.
Frontiers in Immunology|October 4, 2021
Characterizing the Relationship Between Neutralization Sensitivity and <i>env</i> Gene Diversity During ART SuppressionAndrew Wilson, Leyn Shakhtour, Adam Ward, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2018
HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope BreadthsShabnum Patel, Elizabeth Chorvinsky, Shuroug Albihani, et al.
Journal of Virology|March 29, 2019
Modeling HIV-1 Latency Using Primary CD4<sup>+</sup> T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral TherapyHiroshi Takata, Cari Kessing, Aaron Sy, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
AIDS Research and Human Retroviruses|September 11, 2018
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral TherapyNathaniel D Bachtel, Greta A Beckerle, Talia M Mota, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity Zang, Eva M Stevenson, et al.
Pageof 14